Informed choice in direct-to-consumer genetic testing for Alzheimer and other diseases: Lessons from two cases

New Genetics and Society

Volumn 30, Issue 1, 2011, Pages 59-72

  Messner, Donna A ^a  

^a Chemical Heritage Foundation   (United States)

Author keywords

APOE; direct to consumer genetic testing; informed consent

Indexed keywords

ALZHEIMER DISEASE; EMOTION; GENETIC SCREENING; HUMAN; INFORMED CONSENT; PRIORITY JOURNAL; REVIEW;

EID: 79952656739     PISSN: 14636778     EISSN: 14699915     Source Type: Journal    
DOI: 10.1080/14636778.2011.552300     Document Type: Review

References (33)

1. ACMG (American College of Medical Genetics, American Society of Human Genetics and Working Group on ApoE and Alzheimer Disease), 1995. Statement on the use of apolipoprotein E testing for Alzheimer disease. Journal of the American Medical Association, 274 (20), 1627-1629.
2. ADI (Medical and Scientific Advisory Committee and Alzheimer's Disease International), 1995. Consensus statement on genetic testing for Alzheimer disease. Alzheimer Disease and Associated Disorders, 9 (4), 182-187.
3. AMA (Council on Ethical and Judicial Affairs, American Medical Association), 1998. Multiplex genetic testing. Hastings Center Report, 28 (4), 15-21.
4. Baumrind, D., 1979. IRBs and social science research: the costs of deception. IRB: A Review of Human Subjects Research, 1 (6), 1-4.
5. Berger, M.A. and Twerski, A.D., 2005. Uncertainty and informed choice: unmasking Daubert. Michigan Law Review, 104 (2), 257-290.
6. Bird, T.D., 2008. Genetic aspects of Alzheimer disease. Genetics in Medicine, 10 (4), 231-239. (Pubitemid 351544124)
7. Bowen, D.J., Battuello, K.M., and Raats, M., 2005. Marketing genetic tests: empowerment or snake oil? Health Education and Behavior, 32 (5), 676-685.
8. Evans, J.P., Skrzynia, C., and Burke, W., 2001. The complexities of predictive genetic testing. British Medical Journal, 322, 1052-1056. (Pubitemid 32396424)
9. Farrer, L.A., et al., 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. Journal of the American Medical Association, 278, 1349-1356. (Pubitemid 27449696)
10. FTC, 1980. FTC policy statement on unfairness. 17 December [online]. Available from: http://www.ftc.gov/bcp/policystmt/ad-unfair.htm [Accessed 10 June 2010].
11. FTC, 1983. FTC policy statement on deception. 14 October [online]. Available from: http://www.ftc.gov/bcp/policystmt/ad-decept.htm [Accessed 10 June 2010].
12. Gatz, M., et al., 2006. Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry, 63, 168-174. (Pubitemid 43213878)
13. Genetic Alliance, 2009. From risk assessment to lifestyle choices: What does it mean to be a previvor? [Webinar] 22 July 2009, 12:00-1:00 pm ET. Available from http://www.geneticalliance.org/webinars-genetics-advocacy [Accessed 11 February 2011].
14. Gollust, S.E., Hull, S.C., and Wilfond, B.S., 2002. Limitations of direct-to-consumer advertising for clinical genetic testing. Journal of the American Medical Association, 288 (145), 1762-1767.
15. Gray, S. and Olopade, O.I., 2003. Direct-to-consumer marketing of genetic tests for cancer: buyer beware. Journal of Clinical Oncology, 21 (17), 3191-3193.
16. HHS (US Department of Health and Human Services, National Institutes of Health and National Institutes of Aging), 2009. Can Alzheimer's disease be prevented? [online]. NIH Publication No. 09-5503. Available from: http://www.nia.nih.gov/alzheimers/publications/adprevented/ [Accessed 4 February 2010].
17. Holtzman, N.A., et al., 1997. Predictive genetic testing: from basic research to clinical practice. Science, 278 (5338), 602-605. (Pubitemid 27464950)
18. Hull, S.C. and Prasad, K., 2001. Reading between the lines: direct-to-consumer advertising of genetic testing. Hastings Center Report, 31 (3), 33-35.
19. Javitt, G.H. and Hudson, K., 2006. Federal neglect: regulation of genetic testing. Issues in Science and Technology, Spring, 59-66.
20. Javitt, G.H., Stanley, E., and Hudson, K., 2004. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health. Oklahoma Law Review, 57 (2), 251-302.
21. Lock, M., 2005. Eclipse of the gene and the return of divination. Current Anthropology, 46, S47-70.
22. Lock, M., et al., 2006. When it runs in the family: putting susceptibility genes in perspective. Public Understanding of Science, 15 (3), 277-300. (Pubitemid 43862448)
23. Marteau, T. and Richards, M., ed., 1996. The troubled helix: social and psychological implications of the new human genetics. Cambridge: Cambridge University Press.
24. McGuire, A.L. and Lupski, J.R., 2010. Personal genome research: what should the participant be told? Trends in Genetics, 26 (5), 199-201.
25. NIA (National Institute on Aging and Alzheimer's Association Working Group), 1996. Apolipoprotein E genotyping in Alzheimer disease. Lancet, 347 (9008), 1091-1095.
26. Parthasarathy, S., 2007. Building genetic medicine: breast cancer, technology, and the comparative politics of health care. Cambridge, MA and London: The MIT Press.
27. Pollack, A., 2010. Walgreens delays selling personal genetic test kit. New York Times, 13 May, p. B5.
28. Roberts, J.S., et al., 2004. Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial. Genetics in Medicine, 6 (4), 197-203. (Pubitemid 39005859)
29. Robertson, A.S., 2009. Taking responsibility: regulations and protections in direct-to-consumer genetic testing. Berkeley Technology Law Journal, 24, 213-243.
30. Seripa, D., et al., 2004. Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism. Neurology, 62, 1631-1633. (Pubitemid 38608214)
31. Tsuang, D.W. and Bird, T.D., 2002. Genetics of dementia. Medical Clinics of North America, 86 (3), 591-614. (Pubitemid 34810650)
32. Wachbroit, R.S., 1998. The question not asked: the challenge of pleiotropic genetic tests. Kennedy Institute of Ethics Journal, 8 (2), 131-144.
33. Williams-Jones, B., 2006. "Be ready against cancer now": direct-to-consumer advertising for genetic testing. New Genetics and Society, 25 (1), 89-106.